RHYTHM BIOSCIENCES LIMITED - Announcements

0.00%

6.0¢

Market Cap $17.04M

Healthcare Biotechnology

Rhythm Biosciences Ltd is an Australia-based medical diagnostics company. The Company is... Rhythm Biosciences Ltd is an Australia-based medical diagnostics company. The Company is engaged in delivering simple, affordable blood tests for accurate and early detection of cancers. It is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer and saving lives. The Company has developed ColoSTAT, a blood test for the detection of Colorectal Cancer (CRC). The ColoSTAT Test-Kit measures five specific protein biomarkers that indicate the likelihood of CRC. The test is an alternative for individuals who are unable or unwilling to participate in current screening programs. It is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards. The Company also offers population level predictive risk testing for a range of cancers and other serious and common diseases.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RHY	Jun 25 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/25	1.31MB	Share
RHY	Genetype MSK Research Collaboration		24/07/25	335.41KB	Share
RHY	Strategic Genetype Pilot with Leading Australian Pathology		17/07/25	407.02KB	Share
RHY	Change of Director's Interest Notice - Otto Buttula		09/07/25	527.65KB	Share
RHY	Change in substantial holding - Otto Buttula		09/07/25	620.13KB	Share
RHY	Change in substantial holding		03/07/25	198.85KB	Share
RHY	FY2025 R&D Tax Incentive Loan Funding	PRICE SENSITIVE	30/06/25	7.84MB	Share
RHY	NATA Accreditation Awarded for Genetype Laboratory	PRICE SENSITIVE	24/06/25	457.26KB	Share
RHY	Ceasing to be a substantial holder		23/06/25	560.12KB	Share
RHY	Board Composition Update Succession Plan		23/06/25	7.87MB	Share
RHY	Overview of Genetype Presentation		19/06/25	2.75MB	Share
RHY	Genetype Publication Market Update		11/06/25	398.55KB	Share
RHY	Change in substantial holding - Michelle Wing		10/06/25	417.55KB	Share
RHY	Cleansing Notice		02/06/25	357.67KB	Share
RHY	Application for quotation of securities - RHY		02/06/25	15.54KB	Share
RHY	Investor Presentation		02/06/25	1.49MB	Share
RHY	Proposed issue of securities - RHY		30/05/25	14.72KB	Share
RHY	ColoSTAT Beta kit verification and validation update	PRICE SENSITIVE	26/05/25	7.86MB	Share
RHY	Breast Cancer Risk Study University of Melbourne	PRICE SENSITIVE	15/05/25	422.31KB	Share
RHY	Notification regarding unquoted securities - RHY		02/05/25	14.41KB	Share
RHY	Proposed issue of securities - RHY		01/05/25	14.65KB	Share
RHY	Quarterly Activities Report and Appendix 4C 31 March 2025	PRICE SENSITIVE	24/04/25	647.37KB	Share
RHY	RHY ISO13485 Recert Market Update		14/04/25	345.29KB	Share
RHY	Application for quotation of securities - RHY		11/04/25	16.13KB	Share
RHY	Change in substantial holding		08/04/25	211.86KB	Share
RHY	RHY - Results of Meeting		31/03/25	256.26KB	Share
RHY	EGM - Investor Presentation	PRICE SENSITIVE	31/03/25	1.18MB	Share
RHY	RHY Genetype Commercial Sales	PRICE SENSITIVE	19/03/25	330.92KB	Share
RHY	Notification regarding unquoted securities - RHY		18/03/25	16.3KB	Share
RHY	Appointment of Chief Financial Officer		18/03/25	319.98KB	Share
RHY	Notification of cessation of securities - RHY		17/03/25	12.85KB	Share
RHY	RHY Investor Webinar	PRICE SENSITIVE	05/03/25	1.11MB	Share
RHY	RHY - EGM Notice of Meeting and Proxy Form		27/02/25	955.2KB	Share
RHY	Investor Webinar		27/02/25	238.13KB	Share
RHY	Half-Year Financial Report and Appendix 4D	PRICE SENSITIVE	21/02/25	2.64MB	Share
RHY	Becoming a substantial holder		12/02/25	185.39KB	Share
RHY	Genetype Commercial Integration Completion	PRICE SENSITIVE	04/02/25	334.32KB	Share
RHY	Quarterly Activities Report and Appendix 4C - Dec24	PRICE SENSITIVE	23/01/25	2.58MB	Share
RHY	About the Genetype Acquisition	PRICE SENSITIVE	14/01/25	871.64KB	Share
RHY	GTG: GTG completes sale of geneType business and assets		24/12/24	79.2KB	Share
RHY	Completion of Genetype Risk Assessment Portfolio Acquisition	PRICE SENSITIVE	24/12/24	390.59KB	Share
RHY	Notification regarding unquoted securities - RHY		24/12/24	15.94KB	Share
RHY	RHY Acquires Genetype Genetic Risk Assessment Business	PRICE SENSITIVE	23/12/24	519.3KB	Share
RHY	Trading Halt	PRICE SENSITIVE	20/12/24	424.02KB	Share
RHY	Pause in Trading	PRICE SENSITIVE	20/12/24	115.68KB	Share
RHY	Market Update - All End of CY24 Milestones Attained	PRICE SENSITIVE	18/12/24	561.64KB	Share
RHY	Change of Company Auditor		17/12/24	408.32KB	Share
RHY	Change in substantial holding - Otto Buttula		02/12/24	598.12KB	Share
RHY	Initial Director's Interest Notice		02/12/24	149.83KB	Share
RHY	Board Changes Effected		02/12/24	413.6KB	Share
RHY	Application for quotation of securities - RHY		27/11/24	15.89KB	Share
RHY	Final Director's Interest Notice - Lou Panaccio		21/11/24	276.09KB	Share
RHY	Final Director's Interest Notice - Trevor Lockett		21/11/24	273.72KB	Share
RHY	2024 AGM Results		20/11/24	451.85KB	Share
RHY	2024 AGM Chairman's Address & Post AGM Presentation		20/11/24	4.65MB	Share
RHY	Board Composition Update - NED Resignations		20/11/24	527.02KB	Share
RHY	Proposed issue of securities - RHY		19/11/24	18.01KB	Share
RHY	Placement Issue Investor Presentation	PRICE SENSITIVE	19/11/24	4.19MB	Share
RHY	Placement Prospectus	PRICE SENSITIVE	19/11/24	697.46KB	Share
RHY	Strong Demand in Share Placement to Raise $3.5 million	PRICE SENSITIVE	19/11/24	559.65KB	Share
RHY	Notification regarding unquoted securities - RHY		18/11/24	21.88KB	Share
RHY	Notification regarding unquoted securities - RHY		18/11/24	15.93KB	Share
RHY	Awarding of Employee Options and Loan Shares to Management		18/11/24	495.13KB	Share
RHY	Trading Halt	PRICE SENSITIVE	15/11/24	312.21KB	Share
RHY	New, Independent, Non-Executive Director to be Appointed		11/11/24	516.02KB	Share
RHY	Receipt of Research & Development Tax Incentive	PRICE SENSITIVE	07/11/24	355.34KB	Share
RHY	Market Presentation		24/10/24	4.46MB	Share
RHY	Appendix 4C and Market Update	PRICE SENSITIVE	24/10/24	638.32KB	Share
RHY	RHY 2024 AGM Nominations & Proxy Form		18/10/24	551.22KB	Share
RHY	2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms	PRICE SENSITIVE	07/10/24	552.67KB	Share
RHY	Initial Director's Interest Notice - David Atkins		30/09/24	253.49KB	Share
RHY	Board Renewal / Composition Update	PRICE SENSITIVE	30/09/24	510.14KB	Share
RHY	Corporate Governance Statement		26/09/24	877.68KB	Share
RHY	RHY FY2024 Annual Report		26/09/24	7.57MB	Share
RHY	Platform Expansion - Gastric Cancer Diagnostic Test Update	PRICE SENSITIVE	24/09/24	537.95KB	Share
RHY	AGM date and closing date for director nominations		10/09/24	355.6KB	Share
RHY	Appendix 4G		30/08/24	504.16KB	Share
RHY	RHY Financial Report FY2024		30/08/24	977.74KB	Share
RHY	Appendix 4E	PRICE SENSITIVE	30/08/24	269.2KB	Share
RHY	Product and Market Update - Phase 2 Milestone	PRICE SENSITIVE	28/08/24	491.86KB	Share
RHY	Notification of cessation of securities - RHY		19/08/24	12.89KB	Share
RHY	FY2024 R&D Tax Incentive Loan Funding		14/08/24	462.96KB	Share
RHY	Change of Director's Interest Notice - Otto Buttula		07/08/24	277.37KB	Share
RHY	Change of Director's Interest Notice - Lou Panaccio		07/08/24	275.77KB	Share
RHY	Change of Director's Interest Notice - Trevor Lockett		07/08/24	275.95KB	Share
RHY	Notification of cessation of securities - RHY		01/08/24	13.28KB	Share
RHY	Jun 24 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/07/24	2.35MB	Share
RHY	Bioshares Biotech Summit Presentation		12/07/24	4.74MB	Share
RHY	Close of Shortfall Offer Pursuant to the Rights Issue		17/06/24	500.34KB	Share
RHY	Change of Director's Interest Notice - Otto Buttula		17/06/24	278.1KB	Share
RHY	Change of Director's Interest - Otto Buttula		04/06/24	278.11KB	Share
RHY	Change of Director's Interest Notice - Otto Buttula		28/05/24	278.36KB	Share
RHY	Cancel - Notification regarding unquoted securities - RHY		27/05/24	16.25KB	Share
RHY	Notification regarding unquoted securities - RHY		27/05/24	18.61KB	Share
RHY	Notification regarding unquoted securities - RHY		27/05/24	22.76KB	Share
RHY	Notification regarding unquoted securities - RHY		27/05/24	16.46KB	Share
RHY	Otto Buttula to revert back to Non-Executive Chair		22/05/24	357.51KB	Share
RHY	Application for quotation of securities - RHY		07/05/24	16.98KB	Share
RHY	Mar24 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/04/24	598.92KB	Share
RHY	Dr David Atkins appointed Chief Executive Officer of Rhythm	PRICE SENSITIVE	24/04/24	517.7KB	Share

RHY Jun 25 Quarterly Activities Report and Appendix 4C
31/07/25	PRICE SENSITIVE	1.31MB	Share
RHY Genetype MSK Research Collaboration
24/07/25		335.41KB	Share
RHY Strategic Genetype Pilot with Leading Australian Pathology
17/07/25		407.02KB	Share
RHY Change of Director's Interest Notice - Otto Buttula
09/07/25		527.65KB	Share
RHY Change in substantial holding - Otto Buttula
09/07/25		620.13KB	Share
RHY Change in substantial holding
03/07/25		198.85KB	Share
RHY FY2025 R&D Tax Incentive Loan Funding
30/06/25	PRICE SENSITIVE	7.84MB	Share
RHY NATA Accreditation Awarded for Genetype Laboratory
24/06/25	PRICE SENSITIVE	457.26KB	Share
RHY Ceasing to be a substantial holder
23/06/25		560.12KB	Share
RHY Board Composition Update Succession Plan
23/06/25		7.87MB	Share
RHY Overview of Genetype Presentation
19/06/25		2.75MB	Share
RHY Genetype Publication Market Update
11/06/25		398.55KB	Share
RHY Change in substantial holding - Michelle Wing
10/06/25		417.55KB	Share
RHY Cleansing Notice
02/06/25		357.67KB	Share
RHY Application for quotation of securities - RHY
02/06/25		15.54KB	Share
RHY Investor Presentation
02/06/25		1.49MB	Share
RHY Proposed issue of securities - RHY
30/05/25		14.72KB	Share
RHY ColoSTAT Beta kit verification and validation update
26/05/25	PRICE SENSITIVE	7.86MB	Share
RHY Breast Cancer Risk Study University of Melbourne
15/05/25	PRICE SENSITIVE	422.31KB	Share
RHY Notification regarding unquoted securities - RHY
02/05/25		14.41KB	Share
RHY Proposed issue of securities - RHY
01/05/25		14.65KB	Share
RHY Quarterly Activities Report and Appendix 4C 31 March 2025
24/04/25	PRICE SENSITIVE	647.37KB	Share
RHY RHY ISO13485 Recert Market Update
14/04/25		345.29KB	Share
RHY Application for quotation of securities - RHY
11/04/25		16.13KB	Share
RHY Change in substantial holding
08/04/25		211.86KB	Share
RHY RHY - Results of Meeting
31/03/25		256.26KB	Share
RHY EGM - Investor Presentation
31/03/25	PRICE SENSITIVE	1.18MB	Share
RHY RHY Genetype Commercial Sales
19/03/25	PRICE SENSITIVE	330.92KB	Share
RHY Notification regarding unquoted securities - RHY
18/03/25		16.3KB	Share
RHY Appointment of Chief Financial Officer
18/03/25		319.98KB	Share
RHY Notification of cessation of securities - RHY
17/03/25		12.85KB	Share
RHY RHY Investor Webinar
05/03/25	PRICE SENSITIVE	1.11MB	Share
RHY RHY - EGM Notice of Meeting and Proxy Form
27/02/25		955.2KB	Share
RHY Investor Webinar
27/02/25		238.13KB	Share
RHY Half-Year Financial Report and Appendix 4D
21/02/25	PRICE SENSITIVE	2.64MB	Share
RHY Becoming a substantial holder
12/02/25		185.39KB	Share
RHY Genetype Commercial Integration Completion
04/02/25	PRICE SENSITIVE	334.32KB	Share
RHY Quarterly Activities Report and Appendix 4C - Dec24
23/01/25	PRICE SENSITIVE	2.58MB	Share
RHY About the Genetype Acquisition
14/01/25	PRICE SENSITIVE	871.64KB	Share
RHY GTG: GTG completes sale of geneType business and assets
24/12/24		79.2KB	Share
RHY Completion of Genetype Risk Assessment Portfolio Acquisition
24/12/24	PRICE SENSITIVE	390.59KB	Share
RHY Notification regarding unquoted securities - RHY
24/12/24		15.94KB	Share
RHY RHY Acquires Genetype Genetic Risk Assessment Business
23/12/24	PRICE SENSITIVE	519.3KB	Share
RHY Trading Halt
20/12/24	PRICE SENSITIVE	424.02KB	Share
RHY Pause in Trading
20/12/24	PRICE SENSITIVE	115.68KB	Share
RHY Market Update - All End of CY24 Milestones Attained
18/12/24	PRICE SENSITIVE	561.64KB	Share
RHY Change of Company Auditor
17/12/24		408.32KB	Share
RHY Change in substantial holding - Otto Buttula
02/12/24		598.12KB	Share
RHY Initial Director's Interest Notice
02/12/24		149.83KB	Share
RHY Board Changes Effected
02/12/24		413.6KB	Share
RHY Application for quotation of securities - RHY
27/11/24		15.89KB	Share
RHY Final Director's Interest Notice - Lou Panaccio
21/11/24		276.09KB	Share
RHY Final Director's Interest Notice - Trevor Lockett
21/11/24		273.72KB	Share
RHY 2024 AGM Results
20/11/24		451.85KB	Share
RHY 2024 AGM Chairman's Address & Post AGM Presentation
20/11/24		4.65MB	Share
RHY Board Composition Update - NED Resignations
20/11/24		527.02KB	Share
RHY Proposed issue of securities - RHY
19/11/24		18.01KB	Share
RHY Placement Issue Investor Presentation
19/11/24	PRICE SENSITIVE	4.19MB	Share
RHY Placement Prospectus
19/11/24	PRICE SENSITIVE	697.46KB	Share
RHY Strong Demand in Share Placement to Raise $3.5 million
19/11/24	PRICE SENSITIVE	559.65KB	Share
RHY Notification regarding unquoted securities - RHY
18/11/24		21.88KB	Share
RHY Notification regarding unquoted securities - RHY
18/11/24		15.93KB	Share
RHY Awarding of Employee Options and Loan Shares to Management
18/11/24		495.13KB	Share
RHY Trading Halt
15/11/24	PRICE SENSITIVE	312.21KB	Share
RHY New, Independent, Non-Executive Director to be Appointed
11/11/24		516.02KB	Share
RHY Receipt of Research & Development Tax Incentive
07/11/24	PRICE SENSITIVE	355.34KB	Share
RHY Market Presentation
24/10/24		4.46MB	Share
RHY Appendix 4C and Market Update
24/10/24	PRICE SENSITIVE	638.32KB	Share
RHY RHY 2024 AGM Nominations & Proxy Form
18/10/24		551.22KB	Share
RHY 2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms
07/10/24	PRICE SENSITIVE	552.67KB	Share
RHY Initial Director's Interest Notice - David Atkins
30/09/24		253.49KB	Share
RHY Board Renewal / Composition Update
30/09/24	PRICE SENSITIVE	510.14KB	Share
RHY Corporate Governance Statement
26/09/24		877.68KB	Share
RHY RHY FY2024 Annual Report
26/09/24		7.57MB	Share
RHY Platform Expansion - Gastric Cancer Diagnostic Test Update
24/09/24	PRICE SENSITIVE	537.95KB	Share
RHY AGM date and closing date for director nominations
10/09/24		355.6KB	Share
RHY Appendix 4G
30/08/24		504.16KB	Share
RHY RHY Financial Report FY2024
30/08/24		977.74KB	Share
RHY Appendix 4E
30/08/24	PRICE SENSITIVE	269.2KB	Share
RHY Product and Market Update - Phase 2 Milestone
28/08/24	PRICE SENSITIVE	491.86KB	Share
RHY Notification of cessation of securities - RHY
19/08/24		12.89KB	Share
RHY FY2024 R&D Tax Incentive Loan Funding
14/08/24		462.96KB	Share
RHY Change of Director's Interest Notice - Otto Buttula
07/08/24		277.37KB	Share
RHY Change of Director's Interest Notice - Lou Panaccio
07/08/24		275.77KB	Share
RHY Change of Director's Interest Notice - Trevor Lockett
07/08/24		275.95KB	Share
RHY Notification of cessation of securities - RHY
01/08/24		13.28KB	Share
RHY Jun 24 Quarterly Activities Report and Appendix 4C
29/07/24	PRICE SENSITIVE	2.35MB	Share
RHY Bioshares Biotech Summit Presentation
12/07/24		4.74MB	Share
RHY Close of Shortfall Offer Pursuant to the Rights Issue
17/06/24		500.34KB	Share
RHY Change of Director's Interest Notice - Otto Buttula
17/06/24		278.1KB	Share
RHY Change of Director's Interest - Otto Buttula
04/06/24		278.11KB	Share
RHY Change of Director's Interest Notice - Otto Buttula
28/05/24		278.36KB	Share
RHY Cancel - Notification regarding unquoted securities - RHY
27/05/24		16.25KB	Share
RHY Notification regarding unquoted securities - RHY
27/05/24		18.61KB	Share
RHY Notification regarding unquoted securities - RHY
27/05/24		22.76KB	Share
RHY Notification regarding unquoted securities - RHY
27/05/24		16.46KB	Share
RHY Otto Buttula to revert back to Non-Executive Chair
22/05/24		357.51KB	Share
RHY Application for quotation of securities - RHY
07/05/24		16.98KB	Share
RHY Mar24 Quarterly Activities Report and Appendix 4C
30/04/24	PRICE SENSITIVE	598.92KB	Share
RHY Dr David Atkins appointed Chief Executive Officer of Rhythm
24/04/24	PRICE SENSITIVE	517.7KB	Share

REFRESH

1 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.0¢		Change 0.000(0.00%)		Mkt cap ! $17.04M

Open	High	Low	Value	Volume
5.9¢	6.1¢	5.9¢	$23.86K	393.5K

Buyers (Bids)

No.	Vol.	Price($)
1	5214	6.0¢

Sellers (Offers)

Price($)	Vol.	No.
6.1¢	32913	1

View Market Depth

No.	Vol.	Price($)
1	5214	0.060
1	15614	0.059
1	94701	0.057
2	90499	0.056
1	54545	0.055

Price($)	Vol.	No.
0.061	32913	1
0.063	10000	1
0.064	77140	1
0.065	50000	1
0.066	45450	1

Last trade - 11.06am 01/08/2025 (20 minute delay)


Last 6.0¢		Change 0.000 ( 1.18 %)
Open	High	Low	Volume
5.9¢	6.0¢	5.9¢	10027
Last updated 11.06am 01/08/2025 ?

RHY (ASX) Chart

RHYTHM BIOSCIENCES LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

RHYTHM BIOSCIENCES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available